A kind of axial nucleoside asymmetrically modified silicon phthalocyanine and its preparation method and application
An asymmetric, silicon phthalocyanine technology, applied in the field of axial nucleoside asymmetric modification of silicon phthalocyanine and its preparation, can solve the problems of lack of tumor tissue and cancer cell selectivity, high skin phototoxicity, and clinical application limitations. , to achieve the effect of excellent amphiphilicity, clear structure and unique asymmetric substitution characteristics
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Synthesis of bis[5'-(2',3'-O-isopropyl)-uridineoxy]silicon phthalocyanine
[0043] (1) Synthesis of 2',3'-O-isopropyl-uridine
[0044] 245 mg (1 mmol) of uridine is dissolved in 10-30 ml (preferably 20 ml) of acetone, and 8-12 mmol (preferably 10 mmol) of p-toluenesulfonic acid is dissolved in 10-30 ml (preferably 20 ml) of acetone. The acetone p-toluenesulfonic acid solution was slowly added dropwise to the uridine acetone solution in an ice-water bath, and stirred at room temperature for 2 to 10 hours (preferably 6 hours). The reaction mixture was added to an ice-water solution containing 4% sodium bicarbonate, extracted several times with dichloromethane (or chloroform), the organic layer was collected, dried over magnesium sulfate, filtered, concentrated, and dried to obtain a yellow powder product. Yield 85%.
[0045] The characterization data of the product are as follows: MS (EI-60) m / z: 283.4 [M-H] - .
[0046] IR (KBr, cm -1 ): 1467, 2935 (CH 3 ); 1703 (C...
Embodiment 2
[0056]Synthesis of bis[5'-(2',3'-O-isopropyl)-cytidineoxy]silicon phthalocyanine
[0057] (1) Synthesis of 2',3'-O-isopropyl-cytidine
[0058] 250 mg (1 mmol) of cytidine is dissolved in 10-30 ml (preferably 20 ml) of acetone, and 8-12 mmol (preferably 10 mmol) of p-toluenesulfonic acid is dissolved in 10-30 ml (preferably 20 ml) of acetone. The acetone p-toluenesulfonic acid solution was slowly added dropwise to the cytidine acetone solution in an ice-water bath, stirred at room temperature for 4~10h (preferably 6h), centrifuged to collect the white precipitate, washed with acetone three to four times, and dissolved with a small amount of DMF. Ethyl acetate was added for precipitation, membrane filtration, and vacuum drying to obtain a white powdery product with a yield of 95%.
[0059] The characterization data of the product are as follows: IR (KBr, cm -1 ): 1383 (CH 3 ); 1123 (-O-); 1727 (C=O); 3067, 1204, 1650 (NH 2 ); 1693 (C=C); 3067, 1204 (-OH).
[0060] 1 HNMR (...
Embodiment 3
[0068] Synthesis of bis[5'-(2',3'-O-isopropyl)-adenosyloxy]silicon phthalocyanine
[0069] (1) Synthesis of 2',3'-O-isopropyl-adenosine
[0070] Adenosine (1 mmol) is dissolved in 10-30 ml (preferably 20 ml) of acetone, and 8-12 mmol (preferably 10 mmol) of p-toluenesulfonic acid is dissolved in 10-30 ml (preferably 20 ml) of acetone. The acetone p-toluenesulfonic acid solution was slowly added dropwise to the 2-aminoadenosylacetone solution in an ice-water bath, stirred at room temperature for 24~72h (preferably 6h), poured into a 4% aqueous sodium bicarbonate solution, a white precipitate was precipitated, and the Filter and dry. Purified by Soxhlet extraction with chloroform, and dried to obtain a white powder product. Yield 85%.
[0071] (2) Synthesis of bis[5'-(2',3'-O-isopropyl)-adenosyloxy]silicon phthalocyanine
[0072] Under nitrogen protection, dichlorosilicon phthalocyanine (40mg, 0.065mmol), 2',3'-O-isopropyl-adenosine (0.260~0.650mmol, preferably 0.52mmol) and...
PUM
Property | Measurement | Unit |
---|---|---|
wavelength | aaaaa | aaaaa |
wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com